Connect, Collaborate & Create Change

Panelists engaged in a discussion

Connect, Collaborate & Create Change

October 17-19, 2025 | Loews Miami Beach

Claim Credit for CIO 2025

October 17-19 | Loews Miami Beach

- Moderator
  - Yolanda Bryce MD
- Room
  - Cowrie
New to CIO this year, the inaugural Breast Cancer Cryoablation Summit will be taking place on Thursday, September 19th from 2pm-7pm EST. Led by Dr. Yolanda Bryce, this summit will provide attendees with the latest information on the utilization of cryoablation for breast cancer in an interactive format with hands-on experiences provided by our sponsors, Varian, a Siemens Healthineers Company and Boston Scientific.
- 2:00 PM – 2:05 PM
  
  Welcome and Opening Remarks
- 2:05 PM – 2:20 PM
  
  Introduction: Why Cryoablation and Review of the Literature
- 2:20 PM – 2:40 PM
  
  Basics of Breast Cancer Cryoablation Technique
- 2:40 PM – 3:00 PM
  
  More Advanced Breast Cancer Cryoablation Techniques
- 3:00 PM – 3:10 PM
  
  Demonstrating the Technique
- 3:10 PM – 3:30 PM
  
  Refreshment Break
- 3:30 PM – 3:50 PM
  
  Systemic Therapy for Early Stage Breast Cancer
- 3:50 PM – 4:10 PM
  
  Positives and Negatives of Ablative Radiation
- 4:10 PM – 4:30 PM
  
  Following Up Patients/Follow Up Imaging
- 4:30 PM – 5:00 PM
  
  Tumor Board
- 5:00 PM – 5:20 PM
  
  Practice Building
- 5:20 PM – 7:00 PM
  
  Networking Reception and Hands-On

- Room
  - Americana Foyer
- Moderator
  - Nadine Abi-Jaoudeh MD
- Room
  - Poinciana 1&2
- 8:20 AM – 8:30 AM
  
  Understanding Oncology Trials: Clinical Endpoints
- 8:30 AM – 8:40 AM
  
  HCC and CholangioCarcinoma: Diagnosis, Staging, and Treatment Algorithm
- 8:40 AM – 8:50 AM
  
  Metastatic Colorectal Cancer to the Liver: Diagnosis, Staging, and Treatment Algorithm
- 8:50 AM – 9:00 AM
  
  Essentials of Chemotherapy, Immunotherapy, and Targeted Therapy for Liver Cancers
- 9:00 AM – 9:10 AM
  
  Basics of Radiation Therapy for Liver Cancer
- 9:10 AM – 9:20 AM
  
  Hepatic Anatomy: What I Need to Know
- 9:20 AM – 9:30 AM
  
  Hepatic Ablation 101
- 9:30 AM – 9:40 AM
  
  Hepatic Intra-Arterial Treatments 101
- 9:40 AM – 9:50 AM
  
  Portal Vein Embolization
- 9:50 AM – 10:00 AM
  
  Discussion and Audience Q&A
- Room
  - Americana Foyer
- Moderator
  - Constantino Peña MD, FSIR
  - Ripal Gandhi MD
- Room
  - Americana 1-2
- 10:30 AM – 10:40 AM
  
  Welcome and Opening Remarks
- 10:40 AM – 10:50 AM
  
  HCC: Year in Review
- 10:50 AM – 11:00 AM
  
  Advances in Systemic Therapy for HCC
- 11:00 AM – 11:15 AM
  
  HCC Panel: What Else Happened - A Roundtable Discussion
- 11:15 AM – 11:25 AM
  
  Liver Metastatic Disease: Year in Review
- 11:25 AM – 11:40 AM
  
  Liver Metastatic Disease Panel: What Else Happened - A Roundtable Discussion
- 11:40 AM – 11:50 AM
  
  The Evolving Role of Hepatic Ablation
- 11:50 AM – 12:00 PM
  
  Which Liver Patients are Best Treated with External Beam Radiation?
- 12:00 PM – 12:10 PM
  
  Which Liver Patients are Best Treated with Hepatic Resection?
- Speaker
  - Asad Baig MD
  - Nima Kokabi MD
- Room
  - Poinciana 1&2
Moderator: Asad Baig, MD Assistant Professor of Radiology Vascular and Interventional Radiology Columbia University NYP New York, NY Speaker: Nima Kokabi, MD Associate Professor of Radiology Vice Chair of Clinical Research Interventional Oncology Director Cancer Imaging Director University of North Carolina Chapel Hill, NC The Sirtex sponsored lunch symposium "Optimization of Y-90 resin microspheres for personalized treatment intent" featuring Dr. Nima Kokabi and moderated by Dr. Asad Baig will delve into the fundamentals of Y-90 dosimetry crucial for maximizing therapeutic outcomes with SIR-Spheres Y-90 resin microspheres. Through detailed case reviews and discussion, the session will highlight the importance of accurate dosimetry, and the pivotal role SIR-Spheres FLEXdose options play in achieving personalized and precise treatments for patients.
- Speaker
  - Lindsay Thornton MD
  - Osman Ahmed MD
- Room
  - Poinciana 3&4
Join our lunch symposium exploring the current and future landscape of TheraSphere Y-90 Glass Microspheres. See the latest data emphasizing how dose drives durable outcomes and reproducible results, making TheraSphere the unparalleled choice for HCC. Speakers will also delve into the future of TheraSphere, highlighting innovative studies and investments in combination immunotherapy. Discover how Boston Scientific is shaping the future of Y-90 therapy. Sponsored by Boston Scientific
- Moderator
  - Ripal Gandhi MD
- Room
  - Americana 1-2
- 1:35 PM – 1:44 PM
  
  Y90 for HCC: Year in Review
- 1:44 PM – 1:53 PM
  
  Y90 for Cholangiocarcinoma and Metastatic Disease: Year in Review
- 1:53 PM – 2:02 PM
  
  Intercalating and Combining Y90 with Systemic Therapy
- 2:02 PM – 2:11 PM
  
  Practical Y90 Resin Dosimetry: A Case Based Approach
- 2:11 PM – 2:20 PM
  
  Practical Y90 Glass Dosimetry: A Case Based Approach
- 2:20 PM – 2:29 PM
  
  Radiation Segmentectomy: Data and Technique
- 2:29 PM – 2:38 PM
  
  Radiation Segmentectomy for Metastatic Disease: Where do we stand?
- 2:38 PM – 2:47 PM
  
  Advanced Techniques for Flow Diversion and Angiosomal Optimization for Y90
- 2:47 PM – 2:56 PM
  
  Y90 Complication Prevention and Management
- 2:56 PM – 3:05 PM
  
  What's Hot, What's New and What is the Future for Y90?
- 3:05 PM – 3:25 PM
  
  Discussion and Audience Q&A
- Room
  - Americana 3
- Moderator
  - Edward Kim MD
- Room
  - Americana 1-2
- 4:20 PM – 4:50 PM
  
  Practical Approach to Liver Disease: Multidisciplinary Tumor Board
- 4:50 PM – 4:55 PM
  
  Conventional Chemoembolization: My Top 5 Technical Pearls
- 4:55 PM – 5:00 PM
  
  Drug Eluting Bead Chemoembolization: My Top 5 Technical Pearls
- 5:00 PM – 5:05 PM
  
  Intra-Arterial Treatment via Extrahepatic Collaterals: My Top 5 Technical Pearls
- 5:05 PM – 5:10 PM
  
  Parenchymal-Sparing Radioembolization: Flow-Diversion Techniques
- 5:10 PM – 5:15 PM
  
  Pressure enabled drug delivery: Where and When
- 5:15 PM – 5:20 PM
  
  Use of Software for Intra-Arterial Planning and Confirmation: My Top 5 Pearls
- 5:20 PM – 5:25 PM
  
  Portal Vein Embolization: My Top 5 Technical Pearls
- 5:25 PM – 5:30 PM
  
  Hepatic Venous Deprivation: My Top 5 Technical Pearls
- 5:30 PM – 5:35 PM
  
  Challenging Ablations in Difficult Locations: My Top 5 Technical Pearls
- 5:35 PM – 5:40 PM
  
  Ablation of Poorly Visualized Tumors: My Top 5 Technical Pearls
- 5:40 PM – 5:45 PM
  
  Use of Software for Ablation Planning and Confirmation: My Top 5 Pearls
- 5:45 PM – 5:55 PM
  
  Discussion and Audience Q&A
- Room
  - Americana 3

- Moderator
  - Ripal Gandhi MD
- Speaker
  - Ammar Sarwar
  - Ghassan Abou-Alfa MD, MBA
  - Nima Kokabi MD
- Room
  - Poinciana 1&2
Supported by an educational grant from Sirtex.
- Moderator
  - Steven Yevich MD
- Room
  - Americana 1-2
- 8:20 AM – 8:28 AM
  
  Lung Ablation: Year in Review
- 8:28 AM – 8:36 AM
  
  Lung Ablation: Top 5 Clinical and Technical Pearls
- 8:36 AM – 8:44 AM
  
  Renal Ablation: Year in Review
- 8:44 AM – 8:52 AM
  
  Renal Ablation: Top 5 Clinical and Technical Pearls
- 8:52 AM – 9:00 AM
  
  Breast Ablation
- 9:00 AM – 9:08 AM
  
  Thyroid Ablation
- 9:08 AM – 9:16 AM
  
  Pancreatic IRE
- 9:16 AM – 9:30 AM
  
  Discussion and Audience Q&A
- Moderator
  - Barry Katzen MD, FACC, FACR, FSIR
  - Ripal Gandhi MD
- Room
  - Americana 1-2
- 9:30 AM – 9:37 AM
  
  New Frontiers in Pancreatic Cancer: Transarterial and Transvenous Approaches
- 9:37 AM – 9:44 AM
  
  Pulse Electric Fields: Why, How, and When?
- 9:44 AM – 9:51 AM
  
  Radioopaque Y90 Microspheres: Current Status and Potential Advantages
- 9:51 AM – 9:58 AM
  
  Percutaneous Hepatic Perfusion for Metastatic Disease
- 9:58 AM – 10:05 AM
  
  Histotripsy: Ready for Prime Time
- 10:05 AM – 10:12 AM
  
  Robotics: What's New and Where are We Going?
- 10:12 AM – 10:19 AM
  
  Liquid Embolics in Oncology: Potential Future Applications
- 10:19 AM – 10:26 AM
  
  Intratumor Injections: Is it the Future of Oncology Treatments
- 10:26 AM – 10:33 AM
  
  AI in IO 101: What You Need to Know
- 10:33 AM – 10:40 AM
  
  PAE in the setting of Prostate Cancer – Emerging Indications
- 10:40 AM – 10:47 AM
  
  IO & IO
- 10:47 AM – 10:50 AM
  
  Discussion and Audience Q&A
- Room
  - Americana 3
- Speaker
  - Edward Kim MD
  - Gina Landinez MD
  - Osman Ahmed MD
- Room
  - Americana 1-2
Sponsored by Boston Scientific
- Room
  - Americana 3
- Speaker
  - Edward Kim MD
  - Nadine Abi-Jaoudeh MD
  - Nima Kokabi MD
- Room
  - Poinciana 1&2
Sponsored by Varian.
- Moderator
  - Brian Schiro MD
  - Steven Yevich MD
- Room
  - Americana 1-2
- 1:35 PM – 1:44 PM
  
  Musculoskeletal Interventional Oncologic Interventions: Year in Review
- 1:44 PM – 1:53 PM
  
  Benign Musculoskeletal Tumors: Pediatric to Adult
- 1:53 PM – 2:02 PM
  
  Vertebral Augmentation: Top 5 Clinical and Technical Pearls
- 2:02 PM – 2:11 PM
  
  Vertebral Implants: Why and How I Do It
- 2:11 PM – 2:20 PM
  
  Vertebral Ablation: Why and How I Do It
- 2:20 PM – 2:29 PM
  
  Extra-spinal MSK Ablation: Need to know anatomy
- 2:29 PM – 2:38 PM
  
  Extra-spinal MSK Ablation: Tips and Tricks
- 2:38 PM – 2:47 PM
  
  Cementoplasty Outside the Spine: Top 5 Clinical and Technical Pearls
- 2:47 PM – 2:56 PM
  
  Screw Fixation: Slam dunk cases to get you started
- 2:56 PM – 3:10 PM
  
  Discussion and Audience Q&A
- Room
  - Americana 3
- Moderator
  - David Liu MD FSIR FRCPC
- Room
  - Americana 1-2
- 4:00 PM – 4:09 PM
  
  Intra-hepatic cholangiocarcinoma: systemic therapy plus Y90 versus systemic therapy alone
- 4:09 PM – 4:18 PM
  
  2.5 cm HCC without vascular invasion in patient with portal hypertension- Radiation Segmentectomy vs Ablation
- 4:18 PM – 4:28 PM
  
  3 cm HCC in Patient without Hypertension - Ablation vs SBRT vs Surgery
- 4:28 PM – 4:37 PM
  
  Intermediate Risk BCLC B Multifocal HCC: TACE vs TARE
- 4:37 PM – 4:46 PM
  
  Multifocal advanced HCC with vascular invasion: Systemic therapy vs systemic therapy plus locoregional therapy
- 4:46 PM – 4:55 PM
  
  Large HCC with VP2 invasion - SBRT vs. Y90
- 4:55 PM – 5:04 PM
  
  Neuroendocrine Metastases: PRRT vs Locoregional Therapies
- 5:04 PM – 5:13 PM
  
  Lung Metastases: Locoregional Therapy vs External Beam Radiation
- 5:13 PM – 5:22 PM
  
  Painful Spinal Metastases: Locoregional Therapy vs Radiation
- 5:22 PM – 5:31 PM
  
  Bilobar colorectal cancer hepatic metastatic disease: Y90 vs HAI pump
- 5:31 PM – 5:40 PM
  
  Solitary 3 cm Colorectal Cancer Liver Metastasis in nonsurgical patient: External Beam Radiation vs Ablation
- 5:40 PM – 5:49 PM
  
  T1A Renal cell carcinoma: ablation vs resection
- 5:49 PM – 6:00 PM
  
  Discussion and Audience Q&A
- Room
  - Americana 3
- Speaker
  - Brian Schiro MD
  - Jawad Hussain M.D., M.S.
- Room
  - Poinciana 1&2
Sponsored by Medtronic.

- Discussant
  - Adeel Kaiser MD
  - Domenech Asbun MD
- Moderator
  - Ripal Gandhi MD
- Speaker
  - David Liu MD FSIR FRCPC
  - Michael Morse MD
  - Nora Tabori MD
- Room
  - Poinciana 1&2
Supported by educational grants from Eisai Inc. and Merck & Co., Inc., Rahway, NJ, USA.
- Moderator
  - Adam Geronemus MD, FSIR
  - Steven Yevich MD
- Room
  - Americana 1-2
- 8:20 AM – 8:28 AM
  
  Running an Outpatient IO Lab: Lessons Learned
- 8:28 AM – 8:36 AM
  
  Blocks for Pain Management
- 8:36 AM – 8:44 AM
  
  Celiac Plexus and Splanchnic Blocks: How I Do It
- 8:44 AM – 8:52 AM
  
  Intractable Ascites & Pleural Effusions: Tunneled Catheters and Denver Shunt
- 8:52 AM – 9:00 AM
  
  Interventions for DVT and PE in the Cancer Patient
- 9:00 AM – 9:08 AM
  
  Hyperbilirubinemia: Dilated ducts, drugs, cancer
- 9:08 AM – 9:16 AM
  
  Lymphatic Interventions: How I Do It
- 9:16 AM – 9:24 AM
  
  Which Drugs to Watch Out For
- 9:24 AM – 9:32 AM
  
  Economic Value of IR in Cancer Treatment
- 9:32 AM – 9:42 AM
  
  Publications Talk
- 9:42 AM – 9:55 AM
  
  Discussion and Audience Q&A
- Room
  - Poinciana 3&4
Ablation: Boston Scientific, GE, Medtronic, Quantum Surgical, Varian Embolization: Boston Scientific, Sirtex, Varian
- Moderator
  - Nadine Abi-Jaoudeh MD
  - Steven Yevich MD
- Room
  - Americana 1-2
- 11:35 AM – 11:40 AM
  
  Oral Abstract: Radiogenomics of Colorectal Cancer Liver Metastases Intended for Y90 Therapy Identifies KRAS Heterogeneity
- 11:40 AM – 11:45 AM
  
  Oral Abstract: Retrospective Analysis of Length of Stay and Mortality Following Thoracostomy for Malignant Pleural Effusion
- 11:45 AM – 11:51 AM
  
  Case 1
- 11:51 AM – 11:57 AM
  
  Case 2
- 11:57 AM – 12:03 PM
  
  Case 3
- 12:03 PM – 12:09 PM
  
  Case 4
- 12:09 PM – 12:15 PM
  
  Case 5
- 12:15 PM – 12:21 PM
  
  Case 6
- 12:21 PM – 12:27 PM
  
  Case 7
- 12:27 PM – 12:33 PM
  
  Case 8
- 12:33 PM – 12:39 PM
  
  Case 9
- 12:39 PM – 12:45 PM
  
  Case 10
- 12:45 PM – 1:00 PM
  
  Discussion and Audience Q&A